Translational Neural Devices (U44 Clinical Trial Optional)
ArchivedNational Institutes of Health
Description
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities, including translational bench and animal studies, are expected to lead to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. This cooperative agreement will also support the subsequent small clinical study to collect safety and effectiveness data required to support a marketing application or to inform final device design.
Who can apply
- Small businesses
Contact
NIH OER Webmaster <br/>grantsinfo@nih.gov
grantsinfo@nih.gov
- PostedApr 28, 2021
- ClosesDec 20, 2022
- Award ceiling$1,000,000
- Program funding$4,000,000
- CFDA93.853
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro